Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) ROI

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. ROI

Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for the quarter ending 2018-12-29 was 7.74%, a 33.21% increase year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for the quarter ending 2018-09-29 was 4.80%, a 47.79% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for the quarter ending 2018-06-30 was 4.41%, a 50.41% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for the quarter ending 2018-03-31 was 5.88%, a 27.54% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for fiscal 2018 was 7.69%, a 32.87% increase from fiscal 2017.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for fiscal 2017 was 5.79%, a 24.07% decline from fiscal 2016.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for fiscal 2016 was 7.62%, a 20.62% decline from fiscal 2015.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. roi for fiscal 2015 was 9.60%, a 7.06% increase from fiscal 2014.
Available history
2010-12-25 to 2018-12-29
Data captured

Historical ROI

DateROINet income 12 monthNet income 3 monthDebt plus equity
2018-12-297.74%$228.72M$59.66M$2.96B
2018-09-294.80%$139.46M$60.37M$2.91B
2018-06-304.41%$131.51M$53.71M$2.98B
2018-03-315.88%$131.74M$52.63M$2.24B
2017-12-305.81%$125.45M-$29.85M$2.16B
2017-09-309.19%$199.74M$52.47M$2.17B
2017-07-018.90%$184.82M$53.95M$2.08B
2017-04-018.11%$165.78M$46.78M$2.04B
2016-12-317.66%$156.37M$44.68M$2.04B
2016-09-246.84%$143.5M$37.73M$2.1B
2016-06-256.62%$143.33M$35.21M$2.17B
2016-03-269.75%$157.02M$37.14M$1.61B
2015-12-269.67%$151.09M$31.88M$1.56B
2015-09-269.62%$146.4M$37.38M$1.52B
2015-06-279.80%$140.88M$48.51M$1.44B
2015-03-288.76%$127.45M$31.54M$1.46B
2014-12-279.02%$128.2M$27.17M$1.42B
2014-09-278.15%$119.97M$32.04M$1.47B
2014-06-287.89%$118.84M$35.26M$1.51B
2014-03-298.13%$110.74M$32.23M$1.36B
2013-12-287.86%$104.15M$19.10M$1.33B
2013-09-287.87%$103.24M$30.87M$1.31B
2013-06-297.25%$94.21M$27.28M$1.3B
2013-03-306.90%$97.09M$25.58M$1.41B
2012-12-296.96%$97.87M$18.42M$1.41B
2012-09-297.66%$106.57M$21.97M$1.39B
2012-06-307.46%$103.26M$30.47M$1.38B
2012-03-318.17%$105.09M$26.44M$1.29B
2011-12-318.74%$109.98M$27.11M$1.26B
2010-12-25-24.11%-$342.12M-$343.56M$1.42B

Annual ROI

DateROINet income 12 monthDebt plus equity
2018-12-297.69%$228.72M$2.97B
2017-12-305.79%$125.45M$2.17B
2016-12-317.62%$156.37M$2.05B
2015-12-269.60%$151.09M$1.57B
2014-12-278.97%$128.2M$1.43B
2013-12-287.97%$104.15M$1.31B
2012-12-297.71%$97.87M$1.27B
2011-12-318.83%$109.98M$1.25B
2010-12-25-27.86%-$342.12M$1.23B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71